DOI: 10.1128/CVI.00026-16
ABSTRACT
HIV+ subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors. We found that in humans and mice, PIs do not affect antibody production to pneumococcal vaccination.
FOOTNOTES
- Address correspondence to Daniel Mendoza, Daniel.Mendoza{at}bcm.edu
- Copyright © 2016, American Society for Microbiology. All Rights Reserved.